Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06861530Recruiting

A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children

Role: collaborator

NCT04231500Active Not Recruiting

The Skin Microbiome in Graft Versus Host Disease

Role: collaborator

NCT05029414Not ApplicableActive Not Recruiting

EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke

Role: collaborator

NCT05017142Recruiting

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Role: collaborator

NCT04909333Not ApplicableCompleted

Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia

Role: collaborator

NCT02315859Completed

Validation of New Non-Invasive Parameters of Diastolic Suction in the Left Ventricle

Role: collaborator

NCT02510911Not ApplicableTerminated

Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy?

Role: collaborator

All 7 trials loaded